10 completed, 4 terminated, 2 recruiting, 1 active not recruiting. 7 Not applicable, 7 Phase 2, 2 Phase 1, 1 Phase 3.
Follow Pulmonary Neoplasms: new trials by email Literature Review of Pulmonary Neoplasms trials Research Report on Pulmonary Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Feasibility of Fluorescence Imaging With Bevacizumab-800CW During Bronchoscopy injection with 15 mg bevacizumab-800CW before bronchoscopy, injection with 25 mg bevacizumab-800CW before bronchoscopy - Lung Neoplasms, Pulmonary Neoplasms | Phase 2 | Not yet recruiting | University Medical Center Groningen | 20 | 2026-08-17 | 2026-03-30 |
| Enhanced COPD Management in Suspected Lung Cancer Patients Tailored COPD consultations - COPD (Chronic Obstructive Pulmonary Disease), Lung Cancer (Diagnosis) | Not applicable | Recruiting | Ditte Krag-Hansen | 280 | 2026-03-06 | 2026-04-22 |
| Precision Lung Cancer Survivorship Care Intervention Kentucky LEADS Collaborative Lung Cancer Survivorship Care Program, Enhanced Usual Care - Lung Cancer, Pulmonary Neoplasm | Not applicable | Recruiting | Jerod L Stapleton, PhD | 300 | 2024-08-16 | 2026-02-23 |
| Remote Monitoring of Lung Cancer Patient-Reported Outcomes Using Moovcare® Moovcare® use - Lung Cancer, Neoplasms, Lung | Not applicable | Completed | UNC Lineberger Comprehensive Cancer Center | 41 | 2021-09-01 | 2023-10-10 |
| Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation JDQ443, TNO155, tislelizumab - KRAS G12C Mutant Solid Tumors, Carcinoma, Non-Small-Cell Lung | Phase 1 / Phase 2 | Active not recruiting | Novartis Pharmaceuticals | 344 | 2021-02-24 | 2026-10-19 |
| Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer Lung Cancer, Lung Neoplasms | Completed | Mayo Clinic | 64 | 2016-12-01 | 2021-07-21 | |
| MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s) Microwave ablation - Lung Neoplasms, Cancer of Lung | Not applicable | Terminated | Mayo Clinic | 9 | 2016-06-08 | 2023-10-04 |
| RejuvenAir Lobectomy for Safety and Histology RejuvenAir - Lung Neoplasms, Pulmonary Neoplasms | Phase 1 / Phase 2 | Completed | CSA Medical, Inc. | 6 | 2015-08-01 | 2017-05-11 |
| Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma DNA Extraction - Carcinoma, Squamous Cell, Carcinoma, Squamous | Terminated | Mayo Clinic | 22 | 2015-04-08 | 2025-10-14 | |
| A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System Lung Cancer, Lung Neoplasms | Completed | Mayo Clinic | 23 | 2014-08-01 | 2018-03-21 | |
| Study of Arsenic Trioxide in Small Cell Lung Cancer Arsenic Trioxide - Lung Cancer, Cancer of Lung | Phase 2 | Completed | Emory University | 20 | 2011-08-01 | 2021-02-17 |
| A Phase I Study of iPS Cell Generation From Patients With COPD Skin Biopsy - Thoracic Diseases, Respiratory Tract Diseases | Not applicable | Completed | Mayo Clinic | 31 | 2009-09-01 | 2022-09-28 |
| Diagnosis of Lung Lesions by Endobronchial Ultrasound With an Alternative Guide Sheath guide sheath - Pulmonary Neoplasms, Solitary Pulmonary Nodules | Not applicable | Completed | Chang Gung Memorial Hospital | 180 | 2007-04-01 | 2009-06-17 |
| Bronchial Ultrasonography Via a Fibrescope: Pilot Study in Tumoral Disease Dedicated ultrasonographic probe during bronchoscopy - Pulmonary Neoplasms | Terminated | University Hospital, Tours | 20 | 2005-03-01 | 2006-10-06 | |
| Protocol for Radiofrequency Ablation of Pulmonary Neoplasms Radiofrequency Ablation of pulmonary neoplasms - Pulmonary Neoplasms | Not applicable | Terminated | Oncology Specialties, Alabama | 2003-06-01 | 2007-01-12 | |
| Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide SR48692 - Lung Cancer, Pulmonary Neoplasms | Phase 2 / Phase 3 | Completed | Sanofi | 432 | 2002-10-01 | 2008-12-23 |
| Study of Preoperative Docetaxel or Cisplatin (CDDP) + Docetaxel for C-stage IB-II Non-Small Cell Lung Cancer (NSCLC) Preoperative docetaxel-cisplatin combination chemotherapy, Preoperative docetaxel monotherapy - Pulmonary Neoplasms | Phase 2 | Completed | Haruhiko Fukuda | 80 | 2002-10-01 | 2016-09-22 |
| A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer. Gemcitabine, Carboplatin, LY900003 - Carcinoma, Non-Small-Cell Lung, Pulmonary Neoplasms | Phase 2 | Completed | Eli Lilly and Company | 2002-06-01 | 2006-07-19 |
Lung Neoplasms (18) · Carcinoma, Non-Small-Cell Lung (5) · Carcinoma, Squamous Cell (4) · Adenocarcinoma (3) · Carcinoma, Small Cell (2) · Neoplasm Metastasis (2) · Neoplasms (2) · Pulmonary Disease, Chronic Obstructive (2) · Colorectal Neoplasms (1) · Disease (1) · Lung Diseases, Obstructive (1) · Pulmonary Emphysema (1) · Respiratory Tract Diseases (1) · Small Cell Lung Carcinoma (1) · Solitary Pulmonary Nodule (1)
Lung Diseases (18) · Neoplasms by Site (18) · Respiratory Tract Neoplasms (18) · Thoracic Neoplasms (18) · Respiratory Tract Diseases (17) · Neoplasms (16) · Bronchial Neoplasms (6) · Carcinoma (6) · Carcinoma, Bronchogenic (6) · Neoplasms by Histologic Type (6) · Neoplasms, Glandular and Epithelial (6) · Neoplasms, Squamous Cell (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Chronic Disease (2)
Arsenic Trioxide (1) · Carboplatin (1) · Gemcitabine (1) · ISIS 3521 (1) · Injections (1) · JDQ443 (1) · SR 48692 (1) · tislelizumab (1)
Mayo Clinic (5) · CSA Medical, Inc. (1) · Chang Gung Memorial Hospital (1) · Ditte Krag-Hansen (1) · Eli Lilly and Company (1) · Emory University (1) · Haruhiko Fukuda (1) · Jerod L Stapleton, PhD (1) · Novartis Pharmaceuticals (1) · Oncology Specialties, Alabama (1) · Sanofi (1) · UNC Lineberger Comprehensive Cancer Center (1) · University Hospital, Tours (1) · University Medical Center Groningen (1)
United States (11) · France (3) · Netherlands (3) · Australia (2) · Belgium (2) · Canada (2) · Denmark (2) · Germany (2) · Italy (2) · Japan (2) · Spain (2) · Taiwan (2) · Argentina (1) · Brazil (1) · China (1)
Dennis Wigle, MD, PhD (2) · Aaron Mansfield, MD (1) · Dennis A Wigle, MD, PhD (1) · Gita Mody, MD, MPH (1) · Harubumi Kato, MD, PhD (1) · Jamie L Studts, PhD (1) · Jerod L Stapleton, PhD (1) · Kashif Irshad, MDCM, MSc (1) · Marshall T. Schreeder, M.D. (1) · Shanda Blackmon, MD, MPH (1) · Taofeek Owonikoko, MD, PhD (1)
PMID 11750715, PMID 12740516, PMID 27142472, PMID 36399068, PMID 40850860
K23CA164015 (1), R01CA254734 (1)